Emami Limited

EMAMILTD

INE548C01032

Personal Products

Market Closed - Bombay S.E. Other stock markets 06:00:48 2024-05-10 am EDT			5-day change	1st Jan Change
522.4 ^INR	-0.57%		+5.36%	-7.39%

Mar. 28	Emami Acquires Remaining 4.6% Stake in Brillare	MT
Mar. 27	Emami Limited signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.	CI

Emami Limited Appoints (H.C.) CS Adv Mamta Binani as Independent Director on the Board

November 10, 2021 at 08:15 am EST

Emami Limited announced the appointment of Dr. (h.c.) CS Adv Mamta Binani (DIN: 00462925) as an Independent Director on the board of the Company, in Business Standard (National Daily Newspaper) & Aajkaal (Regional Daily Newspaper) on 10th November, 2021.

Latest news about Emami Limited

Emami Acquires Remaining 4.6% Stake in Brillare	Mar. 27	MT
Emami Limited signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.	Mar. 26	CI
Emami to Invest Additional INR19.5 Million in Associate Company	Feb. 28	MT
India Ratings Keeps A- Rating on Emami Paper Mills' Bank Financing; Outlook Stable	Feb. 20	MT
Jefferies Adjusts Emami’s Price Target to INR580 From INR650, Keeps at Buy	Feb. 12	MT
Transcript : Emami Limited, Q3 2024 Earnings Call, Feb 09, 2024	Feb. 09
Emami to Close Unit in Maharashtra, India	Feb. 09	MT
Emami Limited Announces Closing of its Operations at Village Dongari, Maharashtra	Feb. 09	CI
Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24	Feb. 09	CI
Emami Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Emami Paper Mills Names Chief Marketing Officer	Feb. 06	MT
Jefferies Adjusts Emami's Price Target to INR600 From INR560, Keeps at Buy	Nov. 07	MT
Emami's Consolidated Net Profit Slips in Fiscal Q2	Nov. 07	MT
Emami Limited Declares Interim Dividend for the Financial Year 2023-24	Nov. 06	CI
Transcript : Emami Limited, Q2 2024 Earnings Call, Nov 06, 2023	Nov. 06
Emami Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 06	CI
Emami Completes Acquisition of 26% Stake in Axiom Ayurveda	23-10-18	MT
Emami Limited completed the acquisition of 26% stake in Axiom Ayurveda Private Limited	23-10-17	CI
Emami to Acquire 26% Stake in Axiom Ayurveda	23-09-28	MT
Emami Limited entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited.	23-09-27	CI
Emami Limited Announces Change in Management	23-09-22	CI
India's Manipal Hospitals acquires 84% stake in AMRI Hospitals	23-09-20	RE
Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited.	23-09-19	CI
Emami Limited Announces Changes to the Senior Management Personnel	23-09-05	CI
Transcript : Emami Limited - Shareholder/Analyst Call	23-08-23

Chart Emami Limited

Duration

Period

More charts

Company Profile

Emami Limited is an India-based company, which is focused on personal and healthcare businesses in India. The Company is engaged in the business of manufacturing health, beauty and personal care products. The Companyâs brands, including BoroPlus, Navratna, Zandu, Fair and Handsome, Kesh King, Mentho plus balm, Dermicool, 7 Oils in One, HE, Diamond Shine, Emami Golden Beauty, Emami Naturally Fair, Emami Emasol and Creme21. It has a portfolio of over 300 + products based on ayurvedic formulations. Its operations comprise more than 60 countries, including SAARC, MENAP, SEA, Africa, Eastern Europe and the CIS countries. It provides Ayurvedic Antiseptic Cream, Prickly Heat Powder, Doodh Kesar Body Lotion, Vasocare Herbal Petroleum Jelly, Aloe Vera Gel, Hygiene Range, Cool Oil, Extra Thanda, Gold Ayurvedic Oil and others. It has manufacturing units in India and abroad to develop products suited to meet the diverse needs and preferences of consumers in different markets.

Sector

Personal Products

Calendar

2024-05-28 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Emami Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

522.4 INR

Average target price

563.9 INR

Spread / Average Target

+7.93%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Personal Products

	1st Jan change	Capi.
EMAMI LIMITED	-7.39%	2.73B
PROCTER & GAMBLE COMPANY	+13.86%	394B
UNILEVER PLC	+12.84%	134B
COLGATE-PALMOLIVE COMPANY	+19.31%	78.02B
HINDUSTAN UNILEVER LIMITED	-11.50%	66.3B
ESTEE LAUDER	-9.74%	47.33B
KENVUE INC.	-4.60%	39.33B
ESSITY AB	+11.64%	18.09B
GODREJ CONSUMER PRODUCTS LIMITED	+16.77%	16.17B
DABUR INDIA LIMITED	-1.15%	11.68B

Other Personal Products

Emami Limited

Equities

EMAMILTD

INE548C01032

Personal Products

Emami Limited Appoints (H.C.) CS Adv Mamta Binani as Independent Director on the Board

EPS Revisions